IBERE PHARMACEUTICALS's ticker is IBERWS and the CUSIP is G46843119. A total of 37 filers reported holding IBERE PHARMACEUTICALS in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $134,000 | +1.5% | 13,499 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $132,000 | 0.0% | 13,499 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $132,000 | +0.8% | 13,499 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $131,000 | +3.1% | 13,499 | +3.1% | 0.00% | -25.0% |
| Q3 2021 | $127,000 | +3.3% | 13,099 | +3.1% | 0.00% | 0.0% |
| Q2 2021 | $123,000 | – | 12,699 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynwood Capital Management Inc. | 9,800 | $108,054 | 0.10% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |